| Literature DB >> 34537018 |
Khaled Gomaa1, Ahmed R Abdelraheim2, Saad El Gelany1, Eissa M Khalifa1, Ayman M Yousef1, Heba Hassan1.
Abstract
BACKGROUND: Surgical site infection (SSI) is one of the commonest complications following cesarean section (CS) with a reported incidence of 3-20%. SSI causes massive burdens on both the mother and the health care system. Moreover, it is associated with high maternal morbidity and mortality rate of up to 3%. This study aims to determine the incidence, risk factors and management of SSI following CS in a tertiary hospital.Entities:
Keywords: Cesarean section; Incidence; Minia; Risk factors; Surgical site infection
Mesh:
Year: 2021 PMID: 34537018 PMCID: PMC8449867 DOI: 10.1186/s12884-021-04054-3
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Fig. 1SSI among CS deliveries
Basic and obstetric charactersitcs of SSI and control groups
| Variable | SSI group | Control group | P. V | Crude Odds ratio (95% CI) |
|---|---|---|---|---|
| 31.20 ± 4.90 | 30.90 ± 4.80 | 0.15NS | – | |
| < 19 | 95% CI (30.9–31.5) 87 (10.50%) | 95% CI (30.7–31.1) 141 (9.40%) | 0.54NS | 1.12 (0.84–1.49) |
| 20–34 | 678 (81.90%) | 1231 (82.00%) | 1.0 | |
| ≥ 35 | 63 (7.60%) | 128 (8.60%) | 0.89 (0.65–1.23) | |
| Urban | 361 (43.60%) | 676 (45.10%) | 0.50NS | 1.0 |
| Rural | 467 (56.40%) | 824 (54.90%) | 1.06 (0.89–1.26) | |
| 1–4 | 716 (86.50%) | 1372 (91.50%) | 1.0 | |
| > 4 | 112 (13.50%) | 128 (8.50%) | 1.68 (1.28–2.19) | |
| < 37 wks. | 139 (16.80%) | 172 (11.40%) | 1.56 (1.22–1.98) | |
| ≥ 37 wks. | 689 (83.20%) | 1328 (88.60%) | 1.0 | |
| Elective | 156 (18.80%) | 536 (35.70%) | 1.0 | |
| Emergency | 672 (81.20%) | 964 (64.30%) | 2.40 (1.95–2.94) | |
| ≤ 1 h | 112 (13.50%) | 421 (28.10%) | 1.0 | |
| > 1 h | 716 (86.50%) | 1079 (71.90%) | 2.49 (1.98–3.14) | |
| No | 739 (89.30%) | 1433 (95.50%) | 1.0 | |
| Yes | 89 (10.70%) | 67 (4.50%) | 2.58 (1.85–3.58) | |
| < 24 h | 719 (86.80%) | 1382 (92.10%) | 1.0 | |
| ≥ 24 h | 109 (13.20%) | 118 (7.90%) | 1.78 (1.35–2.34) | |
| No | 689 (83.20%) | 1446 (96.40%) | 1.0 | |
| Yes | 139 (16.80%) | 54 (3.60%) | 5.40 (3.89–7.49) | |
| No | 467 (56.40%) | 1297 (86.50%) | 1.0 | |
| Yes | 361 (43.60%) | 203 (13.50%) | 4.93 (4.03–6.04) | |
| No | 271 (32.70%) | 296 (19.70%) | 2.33 (1.86–2.91) | |
| 1–4 | 319 (38.50%) | 599 (39.90%) | 1.35 (1.11–1.66) | |
| > 4 | 238 (28.80%) | 605 (40.40%) | 1.0 | |
| No | 692 (83.60%) | 1342 (89.50%) | 1.0 | |
| Yes | 136 (16.40%) | 158 (10.50%) | 1.67 (1.30–2.14) | |
| No | 745 (90.00%) | 1414 (94.30%) | 1.0 | |
| Yes | 83 (10.00%) | 86 (5.70%) | 1.83 (1.34–2.51) | |
| No | 787 (95.00%) | 1455 (97.00%) | 1.0 | |
| Yes | 41 (5.00%) | 45 (3.00%) | 1.68 (1.09–2.59) | |
NS Not significant P value
*Significant P value
**Highly significant P value
Multivariate analysis of risk factors for SSI
| Variables | Adjusted Odds ratio (AOR) | P. V |
|---|---|---|
| 0.66 (0.51–1.02) | 0.312NS | |
| 1.27 (1.03–1.88) | ||
| 1.12 (0.94–1.66) | ||
| 2.16 (1.62–2.51) | ||
| 2.12 (1.67–2.79) | ||
| 2.21 (1.62–3.09) | ||
| 1.45 (1.06–2.01) | ||
| 4.51 (3.12–6.18) | ||
| 3.99 (3.11–4.74) | ||
| 2.05 (1.66–2.37) | ||
| 1.34 (0.95–1.84) | ||
| 1.37 (1.02–2.13) | ||
| 1.19 (0.92–2.11) |
NS Not significant P value
*Significant P value
**Highly significant P value
Types and management of SSI
| Number (%) of cases ( | |
|---|---|
| Superficial incisional SSI | 390 (47.10%) |
| Deep incisional SSI | 232 (28%) |
| Organ/space SSI | 206 (24.9%) |
| Medical (dressings and antibiotics) | 521 (62.90%) |
| Surgical exploration | 182 (22%) |
| Missing | 125 (15.10%) |
Fig. 2Mortality among SSI group